4.7 Review

Applications of magnetotactic bacteria and magnetosome for cancer treatment: A review emphasizing on practical and mechanistic aspects

期刊

DRUG DISCOVERY TODAY
卷 25, 期 8, 页码 1444-1452

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.06.010

关键词

-

资金

  1. Banque Publique D'investissement (BPI, France)
  2. ANRT [CIFRE 2014/0359, CIFRE 2016/0747, CIFRE 2013/0364, CIFRE 2015/976]
  3. Eurostars program [Nanoneck-2 E9309, Nanoglioma E11778]
  4. Aide a L'innovation Responsible (AIR) Program [A1401025Q]
  5. Agence Nationale de la Recherche (ANR) Mefisto
  6. Nomis Foundation
  7. Paris Region Entreprise
  8. French Research Tax Credit Program (Credit d'Impot Recherche)
  9. University Paris 6
  10. University Paris 11
  11. Paris Biotech Sante

向作者/读者索取更多资源

Magnetotactic bacteria (MTB) synthesize iron oxide (Fe3O4) nanoparticles (NPs), called magnetosomes, with large sizes leading to a ferrimagnetic behavior and a stable magnetic moment at physiological temperature, a chain structure that prevents NP aggregation and promotes uniform NP distribution, and a mineral core of magnetite/maghemite composition, which can be stabilized by an organic coating. Such properties can favor magnetosome administration to humans under certain optimized non-toxic conditions of fabrication. In this review, I describe the fabrication methods, physico-chemical properties, and the anti-tumor activity of different types of MTB/magnetosome preparations, highlighting the bio-compatibility and excellent anti-tumor activity of purified non-pyrogenic magnetosome minerals stabilized by a synthetic chemical compound.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据